Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity

被引:17
作者
Carcel-Trullols, Jaime [1 ]
Kovacs, Attila D. [1 ,2 ]
Pearce, David A. [1 ,2 ]
机构
[1] Sanford Res, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA
[2] Univ South Dakota, Dept Pediat, Sanford Sch Med, Sioux Falls, SD USA
关键词
NEURONAL CEROID LIPOFUSCINOSES; BATTEN DISEASE; CLN3; DISEASE; CATHEPSIN D; PROSAPOSIN; SAPOSINS; HYPEROSMOLARITY; NEURONAL CEROID-LIPOFUSCINOSIS; JUVENILE BATTEN-DISEASE; SAPOSIN-A; CELLS; PROSAPOSIN; PATHWAY; MUTATIONS; MOUSE; DEGRADATION; MECHANISM;
D O I
10.1002/jcb.26039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among Neuronal Ceroid Lipofuscinoses (NCLs), which are childhood fatal neurodegenerative disorders, the juvenile onset form (JNCL) is the most common. JNCL is caused by recessive mutations in the CLN3 gene. CLN3 encodes a lysosomal/endosomal transmembrane protein but its precise function is not completely known. We have previously reported that in baby hamster kidney (BHK) cells stably expressing myc-tagged human CLN3 (myc-CLN3), hyperosmotic conditions drastically increased myc-CLN3 mRNA and protein expression. In the present study, we analyzed the consequences of hyperosmolarity, and increased CLN3 expression on cathepsin D (CTSD) activity and prosaposin processing using BHK cells transiently or stably expressing myc-CLN3. We found that hyperosmolarity increased lysotracker staining of lysosomes, and elevated the levels of myc-CLN3 and lysosome-associated membrane protein-1 (LAMP1). Hyperosmolarity, independently of the expression level of myc-CLN3, decreased the levels of PSAP and saposin D, which are protein cofactors in sphingolipid metabolism. The lysosomal enzyme cathepsin D (CTSD) mediates the proteolytic cleavage of PSAP precursor into saposins A-D. Myc-CLN3 colocalized with CTSD and activity of CTSD decreased as myc-CLN3 expression increased, and clearly decreased under hyperosmotic conditions. Nevertheless, levels of CTSD measured by Western blotting were not altered under any studied condition. Our results suggest a direct involvement of CLN3 in the regulation of CTSD activity. J. Cell. Biochem. 118: 3883-3890, 2017. (c) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:3883 / 3890
页数:8
相关论文
共 37 条
  • [1] CARLSSON SR, 1989, J BIOL CHEM, V264, P20526
  • [2] The yeast model for Batten disease:: Mutations in btn1, btn2, and hsp30 alter pH homeostasis
    Chattopadhyay, S
    Muzaffar, NE
    Sherman, F
    Pearce, DA
    [J]. JOURNAL OF BACTERIOLOGY, 2000, 182 (22) : 6418 - 6423
  • [3] The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking
    Cotman, Susan L.
    Staropoli, John F.
    [J]. CLINICAL LIPIDOLOGY, 2012, 7 (01) : 79 - 91
  • [4] Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage
    Fumarola, C
    La Monica, S
    Guidotti, GG
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (01) : 155 - 165
  • [5] Osmotic Stress Changes the Expression and Subcellular Localization of the Batten Disease Protein CLN3
    Getty, Amanda
    Kovacs, Attila D.
    Lengyel-Nelson, Timea
    Cardillo, Andrew
    Hof, Caitlin
    Chan, Chun-Hung
    Pearce, David A.
    [J]. PLOS ONE, 2013, 8 (06):
  • [6] CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-β protein precursor and cathepsin D in human cells
    Golabek, AA
    Kida, E
    Walus, M
    Kaczmarski, W
    Michalewski, M
    Wisniewski, KE
    [J]. MOLECULAR GENETICS AND METABOLISM, 2000, 70 (03) : 203 - 213
  • [7] Principles of bioactive lipid signalling: lessons from sphingolipids
    Hannun, Yusuf A.
    Obeid, Lina M.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (02) : 139 - 150
  • [8] Cathepsin D targeted by acid sphingomyelinase-derived ceramide
    Heinrich, M
    Wickel, M
    Schneider-Brachert, W
    Sandberg, C
    Gahr, J
    Schwandner, R
    Weber, T
    Brunner, J
    Krönke, M
    Schütze, S
    [J]. EMBO JOURNAL, 1999, 18 (19) : 5252 - 5263
  • [9] Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): Its mechanism and inhibition by ganglioside
    Hiraiwa, M
    Martin, BM
    Kishimoto, Y
    Conner, GE
    Tsuji, S
    OBrien, JS
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 341 (01) : 17 - 24
  • [10] MUTATIONS CAUSING GAUCHER DISEASE
    HOROWITZ, M
    ZIMRAN, A
    [J]. HUMAN MUTATION, 1994, 3 (01) : 1 - 11